Discover what an ANDA is and how it enables generic drug approval. Learn about the Hatch-Waxman Act, bioequivalence testing, and why this process saves the healthcare system billions.
Continue ReadingPatent litigation in the generic drug market is delaying affordable medicines, costing billions annually. Learn how the Hatch-Waxman Act, Orange Book listings, and serial lawsuits block competition-and what’s being done to fix it.
Continue Reading